Cover Image
市場調查報告書

Solvotrin Therapeutics Ltd :產品平台分析

Solvotrin Therapeutics Ltd - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 321333
出版日期 內容資訊 英文 18 Pages
訂單完成後即時交付
價格
Back to Top
Solvotrin Therapeutics Ltd :產品平台分析 Solvotrin Therapeutics Ltd - Product Pipeline Review - 2014
出版日期: 2014年12月15日 內容資訊: 英文 18 Pages
簡介

Solvotrin Therapeutics Ltd 是製造新的化學物質,上市的製藥公司。該公司的產品,有抗轉移藥,大腸癌治療藥,抗血小板作用及阿斯匹林過量的作用引發癌症的化學性預防藥等。識別新藥物標靶進行構築產品平台的研究開發。

本報告提供Solvotrin Therapeutics Ltd 的治療藥開發平台的現狀及各開發階段比較分析、各藥物標靶、作用機制、給藥途徑、分子類型的治療藥的評估、最新的企業新聞和發表、後期階段及中止的計劃相關資訊等。

Solvotrin Therapeutics Ltd的基本資料

  • Solvotrin Therapeutics Ltd概要
  • 主要資訊
  • 企業資料

Solvotrin Therapeutics Ltd :R&D概要

  • 主要的治療範圍

Solvotrin Therapeutics Ltd :開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Solvotrin Therapeutics Ltd :開發中產品概況

  • 初期階段的開發中產品
    • 在前臨床階段的產品/聯合治療模式

Solvotrin Therapeutics Ltd :藥物簡介

  • ST-0701
  • ST-0702
  • ST-0703

Solvotrin Therapeutics Ltd :開發平台分析

  • 各標靶
  • 各分子類型
  • 各作用機制

Solvotrin Therapeutics Ltd :總公司和子公司的所在地

附錄

圖表

目錄
Product Code: GMDHC06666CDB

Summary

Global Markets Direct's, 'Solvotrin Therapeutics Ltd - Product Pipeline Review - 2014', provides an overview of the Solvotrin Therapeutics Ltd's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Solvotrin Therapeutics Ltd's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Solvotrin Therapeutics Ltd including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Solvotrin Therapeutics Ltd's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Solvotrin Therapeutics Ltd's pipeline products

Reasons to buy

  • Evaluate Solvotrin Therapeutics Ltd's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Solvotrin Therapeutics Ltd in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Solvotrin Therapeutics Ltd's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Solvotrin Therapeutics Ltd and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Solvotrin Therapeutics Ltd
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Solvotrin Therapeutics Ltd and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Solvotrin Therapeutics Ltd Snapshot
    • Solvotrin Therapeutics Ltd Overview
    • Key Information
    • Key Facts
  • Solvotrin Therapeutics Ltd - Research and Development Overview
    • Key Therapeutic Areas
  • Solvotrin Therapeutics Ltd - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Solvotrin Therapeutics Ltd - Pipeline Products Glance
    • Solvotrin Therapeutics Ltd - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Solvotrin Therapeutics Ltd - Drug Profiles
    • ST-0701
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ST-0702
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ST-0703
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Solvotrin Therapeutics Ltd - Pipeline Analysis
    • Solvotrin Therapeutics Ltd - Pipeline Products by Target
    • Solvotrin Therapeutics Ltd - Pipeline Products by Molecule Type
    • Solvotrin Therapeutics Ltd - Pipeline Products by Mechanism of Action
  • Solvotrin Therapeutics Ltd - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Solvotrin Therapeutics Ltd, Key Information
  • Solvotrin Therapeutics Ltd, Key Facts
  • Solvotrin Therapeutics Ltd - Pipeline by Indication, 2014
  • Solvotrin Therapeutics Ltd - Pipeline by Stage of Development, 2014
  • Solvotrin Therapeutics Ltd - Monotherapy Products in Pipeline, 2014
  • Solvotrin Therapeutics Ltd - Preclinical, 2014
  • Solvotrin Therapeutics Ltd - Pipeline by Target, 2014
  • Solvotrin Therapeutics Ltd - Pipeline by Molecule Type, 2014
  • Solvotrin Therapeutics Ltd - Pipeline Products by Mechanism of Action, 2014

List of Figures

  • Solvotrin Therapeutics Ltd - Pipeline by Top 10 Indication, 2014
  • Solvotrin Therapeutics Ltd - Pipeline by Top 10 Target, 2014
  • Solvotrin Therapeutics Ltd - Pipeline Products by Top 10 Mechanism of Action, 2014
Back to Top